An affiliate of US-based private equity investment firm HIG Capital is to acquire Brazilian chemical company Elekeiroz from controlling shareholder Itaúsa –InvestimentosItaú.
Under the agreement, HIG will buy 96.5% in shares of the chemical firm from Itaúsa. Additionally, the company plans to acquire the remaining shares as soon as possible.
HIG Latin America managing director and head Fernando Marques Oliveira said: “We are very much looking forward to working with Elekeiroz. The management team has done a terrific job in building a leadership position across all its products and HIG will now support the company in its organic and inorganic growth plans as well as cost efficiency projects.
“We are especially pleased to have the opportunity to work alongside Itaúsa in structuring this transaction to unlock value in an asset, which is no longer part of their investment priorities.
“We have the opportunity to work alongside Itaúsa in structuring this transaction to unlock value in an asset, which is no longer part of its investment priorities.”
“This transaction demonstrates the ability of HIG to partner with leading groups in Brazil to tailor transactions to meet their specific needs.”
Elekeiroz generated sales of more than R$975m ($282.01m) last year and is the lone producer of oxo-alcohols in Latin America and manufacturer of plasticisers in Brazil.
The company runs two production sites in Várzea Paulista and Camaçari, Bahia, and produces phthalic and maleic anhydrides, sulphuric acid and other by-products.
Elekeiroz CEO Marcos De Marchi said: “It is very exciting for us to partner with HIG, that, with its longstanding track record of value creation and the collaborative nature of its investment team, can significantly add to the company’s ambitious projects going forward.”
Upon completion of the transaction, De Marchi and Elekeiroz’s management team, responsible for leading Elekeiroz during the last six years, will continue with the company.
Source: Chemicals Technology
Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.
OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.
The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.